Evidence map›Paper›PMID 22041900›Full record

ArticleThe Journal of biological chemistry2011

Phospholipase Cγ2 (PLCγ2) is key component in Dectin-2 signaling pathway, mediating anti-fungal innate immune responses.

Sara Gorjestani, Mei Yu, Bing Tang, Dekai Zhang, Demin Wang, Xin Lin

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. MYO1F regulates antifungal immunity by regulating acetylation of microtubules.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Phospholipase Cγ2 is critical for CaBMC ophthalmology · 2018
    Article
  10. InsPBMC biology · 2018
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. C-type lectin receptors in tuberculosis: what we know.Medical microbiology and immunology · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sara GorjestaniDepartments of Molecular and Cellular Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030; Cancer Biology Program, The University of Texas, Graduate School of Biomedical Sciences, Houston, Texas 77030.
Mei YuBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin 53226; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China.
Bing TangDepartments of Molecular and Cellular Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030.
Dekai ZhangInstitute of Bioscience and Technology, Texas A&M University, Houston, Texas 77030.
Demin WangBlood Research Institute, Blood Center of Wisconsin, Milwaukee, Wisconsin 53226.
Xin LinDepartments of Molecular and Cellular Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030; Cancer Biology Program, The University of Texas, Graduate School of Biomedical Sciences, Houston, Texas 77030. Electronic address: xllin@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USVersiti Blood Center of Wisconsin · USTexas A&M University · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Transgenic/Knockout CoreP01HL044612 · NHLBI · VERSITI WISCONSIN, INC. · PI NEWMAN, PETER J · 1990 to 2015
$33.4M
PLC?s in B cell biology and autoimmunityR01AI079087 · NIAID · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2008 to 2018
$4.4M
The function of CARD9 in innate immune responsesR01AI050848 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIN, XIN · 2002 to 2012
$2.7M
T Cell receptor-induced NF-kB and JNK activationR01GM065899 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIN, XIN · 2002 to 2011
$2.5M
NCI NIH HHS CA016672NCI NIH HHS P30 CA016672NHLBI NIH HHS P01 HL044612NHLBI NIH HHS P01HL44612NIAID NIH HHS R01 AI050848NIAID NIH HHS R01AI050848NIAID NIH HHS R01 AI079087NIAID NIH HHS R01AI079087NIGMS NIH HHS R01 GM065899NIGMS NIH HHS R01GM065899
6 · The paper itself

Abstract

C-type lectin receptors (CLRs) such as Dectin-2 function as pattern recognition receptors to sense fungal infection. However, the signaling pathways induced by these receptors remain largely unknown. Previous studies suggest that the CLR-induced signaling pathway may utilize similar signaling components as the B cell receptor-induced signaling pathway. Phospholipase Cγ2 (PLCγ2) is a key component in B cell receptor signaling, but its role in other signaling pathways has not been fully characterized. Here, we show that PLCγ2 functions downstream of Dectin-2 in response to the stimulation by the hyphal form of Candida albicans, an opportunistic pathogenic fungus. Using PLCγ2- and PLCγ1-deficient macrophages, we found that the lack of PLCγ2, but not PLCγ1, impairs cytokine production in response to infection with C. albicans. PLCγ2 deficiency results in the defective activation of NF-κB and MAPK and a significantly reduced production of reactive oxygen species following fungal challenge. In addition, PLCγ2-deficient mice are defective in clearing C. albicans infection in vivo. Together, these findings demonstrate that PLCγ2 plays a critical role in CLR-induced signaling pathways, governing antifungal innate immune responses.

Indexed as

AnimalsAntifungal AgentsBone MarrowCandida albicansImmune SystemImmunity, InnateLectinsLectins, C-TypeMacrophagesMaleMAP Kinase Signaling SystemMiceMice, TransgenicNF-kappa BPhospholipase C gammaReactive Oxygen SpeciesAntifungal Agentsdectin-2, mouseLectinsLectins, C-TypeNF-kappa BPhospholipase C gammaReactive Oxygen Species

Identifiers

PMID22041900
PMCPMC3243564
OpenAlexW2032971863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.